Gut Liver Axis and Microbiome
Nov
2026
Description
This session explores microbiome-liver interactions across disease states, including virome and metagenomic signatures in PSC, gut-derived metabolites in fibrosis, and microbiome-linked mechanisms in alcohol-related hepatitis.
Presentations
11:00 AM
- 11:15 AM
Convention Center - Bluebird Ballroom 3DEF
A machine learning-derived gut metabolomic signature predicts reversal of liver fibrosis in patients with chronic hepatitis B
Lu Li | Abstract Presenter
11:15 AM
- 11:30 AM
Convention Center - Bluebird Ballroom 3DEF
Butyrate-Producing Roseburia species Restoration Attenuates Liver Fibrosis by Gut-Liver LPS/TLR4/SMAD Axis.
Satya Priya Dr Sharma, Ph.D. | Abstract Presenter
11:30 AM
- 11:45 AM
Convention Center - Bluebird Ballroom 3DEF
Fecal virome is associated with clinical outcomes in primary sclerosing cholangitis
Srishti Saha, MBBS, MD | Abstract Presenter
11:45 AM
- 12:00 PM
Convention Center - Bluebird Ballroom 3DEF
Humoral Immune Dysfunction Defines High-Risk Cirrhotic Ascites
Arielle Klepper, MD, PhD | Abstract Presenter
12:00 PM
- 12:15 PM
Convention Center - Bluebird Ballroom 3DEF
Exercise Reprograms a Bacteroides uniformis-Centric Microbial Network to Activate Glycosaminoglycan Degradation in Pediatric MASLD
Yan Ni, Ph.D. | Abstract Presenter
12:15 PM
- 12:30 PM
Convention Center - Bluebird Ballroom 3DEF
Long-read metagenomics reveals distinct transkingdom microbial signatures and phage-bacteria interactions across the cholestatic liver disease spectrum
Prooksa Ananchuensook, MD | Abstract Presenter
